New Key Statistics Module, Z-Score and F-Score
NAS:TNXP Key Ratios
| Market Cap $ M | 16.41 |
| Enterprise Value $ M | 2.19 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.10 |
| Price/Sales | 0.54 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 7.00 |
| EPS (TTM) $ | -8.23 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 78.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.02 |
| EV-to-EBITDA | -0.02 |
| PEG | -- |
| Shares Outstanding M | 95.54 |
| Net Margin (%) | -1,501.78 |
| Operating Margin % | -1,523.94 |
| Pre-tax Margin (%) | -1,501.78 |
| Quick Ratio | 1.78 |
| Current Ratio | 2.53 |
| ROA % (ttm) | -67.96 |
| ROE % (ttm) | -78.88 |
| ROIC % (ttm) | -107.65 |
| Dividend Yield % | -- |
| Altman Z-Score | -7.45 |
TNXP Number of Guru Trades
TNXP Volume of Guru Trades
Gurus Latest Trades with NAS:TNXP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TNXP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tonix Pharmaceuticals Holding Corp Insider Transactions
No Available Data
News about NAS:TNXP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers